ArticleJournal of translational medicine2018

Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.

Hai-Min Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.